|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States. |
| 公司地址
| 105 Piccadilly, Second Floor, London, GBR, W1J 7NJ |
| 電話號碼
| +44 7814319100 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.kiniksa.com |
| 員工數量
| 366 |
| Mr. Michael R. Megna |
Chief Accounting Officer and Senior Vice President, Finance |
-- |
16/04/2026 |
| Mr. Sanj K. Patel |
Chief Executive Officer and Chairman of the Board |
美元 943.13K |
16/04/2026 |
| Dr. John F. Paolini, M.D. |
Executive Vice President and Chief Medical Officer |
美元 585.09K |
16/04/2026 |
| Mr. Mark Ragosa |
Executive Vice President and Chief Financial Officer |
美元 552.80K |
16/04/2026 |
| Mr. Ross Moat |
Chief Operating Officer |
美元 586.27K |
14/01/2026 |
|
|
| Dr. Barry D. Quart,Pharm.D. |
Independent Director |
16/04/2026 |
| Mr. G. Bradley Cole |
Independent Director |
16/04/2026 |
| Ms. Kimberly J. Popovits |
Independent Director |
16/04/2026 |
| Mr. Thomas R. Malley |
Independent Director |
16/04/2026 |
| Dr. Felix J. Baker, PhD |
Lead Independent Director |
16/04/2026 |
| Dr. Stephen R. Biggar,M.D.,PhD |
Independent Director |
16/04/2026 |
| Dr. Richard S. Levy,M.D. |
Independent Director |
16/04/2026 |
| Mr. Sanj K. Patel |
Chief Executive Officer and Chairman of the Board |
16/04/2026 |
| Ms. Tracey L. McCain, Esq. |
Independent Director |
16/04/2026 |
| Ms. Meta Cantey Boyd |
Independent Director |
16/04/2026 |
|
|
|
|
